Lovastatin and Emla drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lovastatin (lovastatin) and Emla (lidocaine; prilocaine). Common drug interactions include haemoglobin decreased among females and lentigo maligna stage unspecified among males.

The phase IV clinical study analyzes what interactions people have when they take Lovastatin and Emla. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Lovastatin?

Lovastatin has active ingredients of lovastatin. It is often used in high blood cholesterol. eHealthMe is studying from 33,048 Lovastatin users. Check the latest studies of Lovastatin.

What is Emla?

Emla has active ingredients of lidocaine; prilocaine. eHealthMe is studying from 5,276 Emla users. Check the latest studies of Emla.

On Jul, 10, 2026

18 people who take Lovastatin and Emla together, and have interactions are studied.

What are the common drug interactions of Lovastatin and Emla, by gender? *:

female:

Haemoglobin decreased
Platelet count decreased
Headache (pain in head)
Hypoaesthesia (reduced sense of touch or sensation)
Abdominal hernia
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Constipation
Diarrhoea
Drug ineffective
Full blood count decreased

male:

Lentigo maligna stage unspecified (colour forming cells cancer of in situ on skin unspecified)
Anaemia (lack of blood)
Aortic stenosis (obstruction to the outflow of blood from the left ventricle into the aorta)
Cardiac failure congestive
Disease progression
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Malignant neoplasm progression (cancer tumour came back)
Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
Rectal haemorrhage (bleeding from anus)

What are the common drug interactions of Lovastatin and Emla, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Arthralgia (joint pain)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Back pain
Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
Bone marrow disorder
Contusion (a type of hematoma of tissue in which capillaries)
Disease progression
Drug ineffective
Fall
Fatigue (feeling of tiredness)

60+:

Lentigo maligna stage unspecified (colour forming cells cancer of in situ on skin unspecified)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Dry mouth
Fatigue (feeling of tiredness)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Malignant neoplasm progression (cancer tumour came back)
Muscle spasms (muscle contraction)
Rectal haemorrhage (bleeding from anus)
Syncope (loss of consciousness with an inability to maintain postural tone)
Visual impairment

What are the existing conditions these people have? *

Nausea (feeling of having an urge to vomit): 9 people, 50.00%
Multiple Myeloma (cancer of the plasma cells): 5 people, 27.78%
Renal Cell Carcinoma (a kidney cancer): 3 people, 16.67%
Nausea And Vomiting: 3 people, 16.67%
Urinary Tract Infection: 2 people, 11.11%
Herpes Simplex (herpes simplex is a common viral infection): 2 people, 11.11%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 11.11%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 11.11%
Constipation: 2 people, 11.11%
Cough: 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Lovastatin and Emla?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously